Antiprotozoal agents (ATC code: ATC P01) is a class of pharmaceuticals used in treatment of protozoan infection.
This report aims to provide a comprehensive presentation of the global market for Antiprotozoal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiprotozoal Drugs. This report contains market size and forecasts of Antiprotozoal Drugs in global, including the following market information:
Global Antiprotozoal Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Antiprotozoal Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Antiprotozoals are used to treat protozoal infections, which include amebiasis, giardiasis, cryptosporidiosis, microsporidiosis, malaria, babesiosis, trypanosomiasis, Chagas disease, leishmaniasis, and toxoplasmosis.[5] Currently, many of the treatments for these infections are limited by their toxicity. Some antiprotozoal drugs include the antimalarials Aralen (chloroquine), Daraprim (pyrimethamine), Lariam (mefloquine) and Plaquenil (hydroxychloroquine); Flagyl (metronidazole) which is active against Entamoeba histolytica and Trichomonas vaginalis; and Mepron (atovaquone) for Pneumocystis carinii.
We surveyed the Antiprotozoal Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiprotozoal Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Antiprotozoal Drugs Market Segment Percentages, by Type, 2022 (%)
by Diseases
Amoebic Dysentery
Antimalarial Drug
Leishmaniasis & Chagas Disease
by Drugs
Metronidazole
Atovaquone
Benznidazole
Dehydroemetine
Eflornithine
Emetine
Fenbendazole
Iodoquinol
Melarsoprol
Others (like Meglumine antimonite, Nifurtimox, Pentamidine, etc.)
Global Antiprotozoal Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Antiprotozoal Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Antiprotozoal Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Antiprotozoal Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiprotozoal Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Antiprotozoal Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Akthelia Pharmaceuticals Ltd
GlaxoSmithKline Plc
Immuron Ltd
Microbiotix Inc
Protein Potential LLC
Dr. Reddy?s Laboratories
Mission Pharmacal
Aceto Corp.
Mylan Pharmaceuticals
Impax Laboratories
Pfizer
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals
Gilead Sciences
Johnson & Johnson
Bristol-Myers Squibb
Profounda
Knight Therapeutics
Albert David
Wanlong
Fangsheng
KPC Pharmaceuticals
Guilin Pharmaceuticals
Pude Pharmaceutica
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antiprotozoal Drugs, market overview.
Chapter 2: Global Antiprotozoal Drugs market size in revenue.
Chapter 3: Detailed analysis of Antiprotozoal Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antiprotozoal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antiprotozoal Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antiprotozoal Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiprotozoal Drugs Overall Market Size
2.1 Global Antiprotozoal Drugs Market Size: 2022 VS 2030
2.2 Global Antiprotozoal Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antiprotozoal Drugs Players in Global Market
3.2 Top Global Antiprotozoal Drugs Companies Ranked by Revenue
3.3 Global Antiprotozoal Drugs Revenue by Companies
3.4 Top 3 and Top 5 Antiprotozoal Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antiprotozoal Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiprotozoal Drugs Players in Global Market
3.6.1 List of Global Tier 1 Antiprotozoal Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Antiprotozoal Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antiprotozoal Drugs Market Size Markets, 2022 & 2030
4.1.2 Amoebic Dysentery
4.1.3 Antimalarial Drug
4.1.4 Leishmaniasis & Chagas Disease
4.2 By Type - Global Antiprotozoal Drugs Revenue & Forecasts
4.2.1 By Type - Global Antiprotozoal Drugs Revenue, 2018-2023
4.2.2 By Type - Global Antiprotozoal Drugs Revenue, 2024-2030
4.2.3 By Type - Global Antiprotozoal Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antiprotozoal Drugs Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Antiprotozoal Drugs Revenue & Forecasts
5.2.1 By Application - Global Antiprotozoal Drugs Revenue, 2018-2023
5.2.2 By Application - Global Antiprotozoal Drugs Revenue, 2024-2030
5.2.3 By Application - Global Antiprotozoal Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Antiprotozoal Drugs Market Size, 2022 & 2030
6.2 By Region - Global Antiprotozoal Drugs Revenue & Forecasts
6.2.1 By Region - Global Antiprotozoal Drugs Revenue, 2018-2023
6.2.2 By Region - Global Antiprotozoal Drugs Revenue, 2024-2030
6.2.3 By Region - Global Antiprotozoal Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Antiprotozoal Drugs Revenue, 2018-2030
6.3.2 US Antiprotozoal Drugs Market Size, 2018-2030
6.3.3 Canada Antiprotozoal Drugs Market Size, 2018-2030
6.3.4 Mexico Antiprotozoal Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Antiprotozoal Drugs Revenue, 2018-2030
6.4.2 Germany Antiprotozoal Drugs Market Size, 2018-2030
6.4.3 France Antiprotozoal Drugs Market Size, 2018-2030
6.4.4 U.K. Antiprotozoal Drugs Market Size, 2018-2030
6.4.5 Italy Antiprotozoal Drugs Market Size, 2018-2030
6.4.6 Russia Antiprotozoal Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Antiprotozoal Drugs Market Size, 2018-2030
6.4.8 Benelux Antiprotozoal Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Antiprotozoal Drugs Revenue, 2018-2030
6.5.2 China Antiprotozoal Drugs Market Size, 2018-2030
6.5.3 Japan Antiprotozoal Drugs Market Size, 2018-2030
6.5.4 South Korea Antiprotozoal Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Antiprotozoal Drugs Market Size, 2018-2030
6.5.6 India Antiprotozoal Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Antiprotozoal Drugs Revenue, 2018-2030
6.6.2 Brazil Antiprotozoal Drugs Market Size, 2018-2030
6.6.3 Argentina Antiprotozoal Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antiprotozoal Drugs Revenue, 2018-2030
6.7.2 Turkey Antiprotozoal Drugs Market Size, 2018-2030
6.7.3 Israel Antiprotozoal Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Antiprotozoal Drugs Market Size, 2018-2030
6.7.5 UAE Antiprotozoal Drugs Market Size, 2018-2030
7 Antiprotozoal Drugs Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Antiprotozoal Drugs Major Product Offerings
7.1.4 Sanofi Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Akthelia Pharmaceuticals Ltd
7.2.1 Akthelia Pharmaceuticals Ltd Company Summary
7.2.2 Akthelia Pharmaceuticals Ltd Business Overview
7.2.3 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Major Product Offerings
7.2.4 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.2.5 Akthelia Pharmaceuticals Ltd Key News & Latest Developments
7.3 GlaxoSmithKline Plc
7.3.1 GlaxoSmithKline Plc Company Summary
7.3.2 GlaxoSmithKline Plc Business Overview
7.3.3 GlaxoSmithKline Plc Antiprotozoal Drugs Major Product Offerings
7.3.4 GlaxoSmithKline Plc Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.3.5 GlaxoSmithKline Plc Key News & Latest Developments
7.4 Immuron Ltd
7.4.1 Immuron Ltd Company Summary
7.4.2 Immuron Ltd Business Overview
7.4.3 Immuron Ltd Antiprotozoal Drugs Major Product Offerings
7.4.4 Immuron Ltd Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.4.5 Immuron Ltd Key News & Latest Developments
7.5 Microbiotix Inc
7.5.1 Microbiotix Inc Company Summary
7.5.2 Microbiotix Inc Business Overview
7.5.3 Microbiotix Inc Antiprotozoal Drugs Major Product Offerings
7.5.4 Microbiotix Inc Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.5.5 Microbiotix Inc Key News & Latest Developments
7.6 Protein Potential LLC
7.6.1 Protein Potential LLC Company Summary
7.6.2 Protein Potential LLC Business Overview
7.6.3 Protein Potential LLC Antiprotozoal Drugs Major Product Offerings
7.6.4 Protein Potential LLC Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.6.5 Protein Potential LLC Key News & Latest Developments
7.7 Dr. Reddy?s Laboratories
7.7.1 Dr. Reddy?s Laboratories Company Summary
7.7.2 Dr. Reddy?s Laboratories Business Overview
7.7.3 Dr. Reddy?s Laboratories Antiprotozoal Drugs Major Product Offerings
7.7.4 Dr. Reddy?s Laboratories Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.7.5 Dr. Reddy?s Laboratories Key News & Latest Developments
7.8 Mission Pharmacal
7.8.1 Mission Pharmacal Company Summary
7.8.2 Mission Pharmacal Business Overview
7.8.3 Mission Pharmacal Antiprotozoal Drugs Major Product Offerings
7.8.4 Mission Pharmacal Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.8.5 Mission Pharmacal Key News & Latest Developments
7.9 Aceto Corp.
7.9.1 Aceto Corp. Company Summary
7.9.2 Aceto Corp. Business Overview
7.9.3 Aceto Corp. Antiprotozoal Drugs Major Product Offerings
7.9.4 Aceto Corp. Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.9.5 Aceto Corp. Key News & Latest Developments
7.10 Mylan Pharmaceuticals
7.10.1 Mylan Pharmaceuticals Company Summary
7.10.2 Mylan Pharmaceuticals Business Overview
7.10.3 Mylan Pharmaceuticals Antiprotozoal Drugs Major Product Offerings
7.10.4 Mylan Pharmaceuticals Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.10.5 Mylan Pharmaceuticals Key News & Latest Developments
7.11 Impax Laboratories
7.11.1 Impax Laboratories Company Summary
7.11.2 Impax Laboratories Business Overview
7.11.3 Impax Laboratories Antiprotozoal Drugs Major Product Offerings
7.11.4 Impax Laboratories Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.11.5 Impax Laboratories Key News & Latest Developments
7.12 Pfizer
7.12.1 Pfizer Company Summary
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Antiprotozoal Drugs Major Product Offerings
7.12.4 Pfizer Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.12.5 Pfizer Key News & Latest Developments
7.13 Lupin Pharmaceuticals
7.13.1 Lupin Pharmaceuticals Company Summary
7.13.2 Lupin Pharmaceuticals Business Overview
7.13.3 Lupin Pharmaceuticals Antiprotozoal Drugs Major Product Offerings
7.13.4 Lupin Pharmaceuticals Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.13.5 Lupin Pharmaceuticals Key News & Latest Developments
7.14 Glenmark Pharmaceuticals
7.14.1 Glenmark Pharmaceuticals Company Summary
7.14.2 Glenmark Pharmaceuticals Business Overview
7.14.3 Glenmark Pharmaceuticals Antiprotozoal Drugs Major Product Offerings
7.14.4 Glenmark Pharmaceuticals Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.14.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.15 Sun Pharmaceutical
7.15.1 Sun Pharmaceutical Company Summary
7.15.2 Sun Pharmaceutical Business Overview
7.15.3 Sun Pharmaceutical Antiprotozoal Drugs Major Product Offerings
7.15.4 Sun Pharmaceutical Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.15.5 Sun Pharmaceutical Key News & Latest Developments
7.16 Heritage Pharmaceuticals
7.16.1 Heritage Pharmaceuticals Company Summary
7.16.2 Heritage Pharmaceuticals Business Overview
7.16.3 Heritage Pharmaceuticals Antiprotozoal Drugs Major Product Offerings
7.16.4 Heritage Pharmaceuticals Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.16.5 Heritage Pharmaceuticals Key News & Latest Developments
7.17 Gilead Sciences
7.17.1 Gilead Sciences Company Summary
7.17.2 Gilead Sciences Business Overview
7.17.3 Gilead Sciences Antiprotozoal Drugs Major Product Offerings
7.17.4 Gilead Sciences Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.17.5 Gilead Sciences Key News & Latest Developments
7.18 Johnson & Johnson
7.18.1 Johnson & Johnson Company Summary
7.18.2 Johnson & Johnson Business Overview
7.18.3 Johnson & Johnson Antiprotozoal Drugs Major Product Offerings
7.18.4 Johnson & Johnson Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.18.5 Johnson & Johnson Key News & Latest Developments
7.19 Bristol-Myers Squibb
7.19.1 Bristol-Myers Squibb Company Summary
7.19.2 Bristol-Myers Squibb Business Overview
7.19.3 Bristol-Myers Squibb Antiprotozoal Drugs Major Product Offerings
7.19.4 Bristol-Myers Squibb Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.19.5 Bristol-Myers Squibb Key News & Latest Developments
7.20 Profounda
7.20.1 Profounda Company Summary
7.20.2 Profounda Business Overview
7.20.3 Profounda Antiprotozoal Drugs Major Product Offerings
7.20.4 Profounda Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.20.5 Profounda Key News & Latest Developments
7.21 Knight Therapeutics
7.21.1 Knight Therapeutics Company Summary
7.21.2 Knight Therapeutics Business Overview
7.21.3 Knight Therapeutics Antiprotozoal Drugs Major Product Offerings
7.21.4 Knight Therapeutics Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.21.5 Knight Therapeutics Key News & Latest Developments
7.22 Albert David
7.22.1 Albert David Company Summary
7.22.2 Albert David Business Overview
7.22.3 Albert David Antiprotozoal Drugs Major Product Offerings
7.22.4 Albert David Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.22.5 Albert David Key News & Latest Developments
7.23 Wanlong
7.23.1 Wanlong Company Summary
7.23.2 Wanlong Business Overview
7.23.3 Wanlong Antiprotozoal Drugs Major Product Offerings
7.23.4 Wanlong Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.23.5 Wanlong Key News & Latest Developments
7.24 Fangsheng
7.24.1 Fangsheng Company Summary
7.24.2 Fangsheng Business Overview
7.24.3 Fangsheng Antiprotozoal Drugs Major Product Offerings
7.24.4 Fangsheng Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.24.5 Fangsheng Key News & Latest Developments
7.25 KPC Pharmaceuticals
7.25.1 KPC Pharmaceuticals Company Summary
7.25.2 KPC Pharmaceuticals Business Overview
7.25.3 KPC Pharmaceuticals Antiprotozoal Drugs Major Product Offerings
7.25.4 KPC Pharmaceuticals Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.25.5 KPC Pharmaceuticals Key News & Latest Developments
7.26 Guilin Pharmaceuticals
7.26.1 Guilin Pharmaceuticals Company Summary
7.26.2 Guilin Pharmaceuticals Business Overview
7.26.3 Guilin Pharmaceuticals Antiprotozoal Drugs Major Product Offerings
7.26.4 Guilin Pharmaceuticals Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.26.5 Guilin Pharmaceuticals Key News & Latest Developments
7.27 Pude Pharmaceutica
7.27.1 Pude Pharmaceutica Company Summary
7.27.2 Pude Pharmaceutica Business Overview
7.27.3 Pude Pharmaceutica Antiprotozoal Drugs Major Product Offerings
7.27.4 Pude Pharmaceutica Antiprotozoal Drugs Revenue in Global Market (2018-2023)
7.27.5 Pude Pharmaceutica Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antiprotozoal Drugs Market Opportunities & Trends in Global Market
Table 2. Antiprotozoal Drugs Market Drivers in Global Market
Table 3. Antiprotozoal Drugs Market Restraints in Global Market
Table 4. Key Players of Antiprotozoal Drugs in Global Market
Table 5. Top Antiprotozoal Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antiprotozoal Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antiprotozoal Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antiprotozoal Drugs Product Type
Table 9. List of Global Tier 1 Antiprotozoal Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiprotozoal Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Antiprotozoal Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Antiprotozoal Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antiprotozoal Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Antiprotozoal Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Antiprotozoal Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antiprotozoal Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Antiprotozoal Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Antiprotozoal Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antiprotozoal Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antiprotozoal Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antiprotozoal Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antiprotozoal Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antiprotozoal Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antiprotozoal Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Sanofi Company Summary
Table 31. Sanofi Antiprotozoal Drugs Product Offerings
Table 32. Sanofi Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Akthelia Pharmaceuticals Ltd Company Summary
Table 35. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Product Offerings
Table 36. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Akthelia Pharmaceuticals Ltd Key News & Latest Developments
Table 38. GlaxoSmithKline Plc Company Summary
Table 39. GlaxoSmithKline Plc Antiprotozoal Drugs Product Offerings
Table 40. GlaxoSmithKline Plc Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. GlaxoSmithKline Plc Key News & Latest Developments
Table 42. Immuron Ltd Company Summary
Table 43. Immuron Ltd Antiprotozoal Drugs Product Offerings
Table 44. Immuron Ltd Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Immuron Ltd Key News & Latest Developments
Table 46. Microbiotix Inc Company Summary
Table 47. Microbiotix Inc Antiprotozoal Drugs Product Offerings
Table 48. Microbiotix Inc Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Microbiotix Inc Key News & Latest Developments
Table 50. Protein Potential LLC Company Summary
Table 51. Protein Potential LLC Antiprotozoal Drugs Product Offerings
Table 52. Protein Potential LLC Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Protein Potential LLC Key News & Latest Developments
Table 54. Dr. Reddy?s Laboratories Company Summary
Table 55. Dr. Reddy?s Laboratories Antiprotozoal Drugs Product Offerings
Table 56. Dr. Reddy?s Laboratories Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Dr. Reddy?s Laboratories Key News & Latest Developments
Table 58. Mission Pharmacal Company Summary
Table 59. Mission Pharmacal Antiprotozoal Drugs Product Offerings
Table 60. Mission Pharmacal Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Mission Pharmacal Key News & Latest Developments
Table 62. Aceto Corp. Company Summary
Table 63. Aceto Corp. Antiprotozoal Drugs Product Offerings
Table 64. Aceto Corp. Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Aceto Corp. Key News & Latest Developments
Table 66. Mylan Pharmaceuticals Company Summary
Table 67. Mylan Pharmaceuticals Antiprotozoal Drugs Product Offerings
Table 68. Mylan Pharmaceuticals Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Mylan Pharmaceuticals Key News & Latest Developments
Table 70. Impax Laboratories Company Summary
Table 71. Impax Laboratories Antiprotozoal Drugs Product Offerings
Table 72. Impax Laboratories Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Impax Laboratories Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Antiprotozoal Drugs Product Offerings
Table 76. Pfizer Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Pfizer Key News & Latest Developments
Table 78. Lupin Pharmaceuticals Company Summary
Table 79. Lupin Pharmaceuticals Antiprotozoal Drugs Product Offerings
Table 80. Lupin Pharmaceuticals Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Lupin Pharmaceuticals Key News & Latest Developments
Table 82. Glenmark Pharmaceuticals Company Summary
Table 83. Glenmark Pharmaceuticals Antiprotozoal Drugs Product Offerings
Table 84. Glenmark Pharmaceuticals Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Glenmark Pharmaceuticals Key News & Latest Developments
Table 86. Sun Pharmaceutical Company Summary
Table 87. Sun Pharmaceutical Antiprotozoal Drugs Product Offerings
Table 88. Sun Pharmaceutical Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Sun Pharmaceutical Key News & Latest Developments
Table 90. Heritage Pharmaceuticals Company Summary
Table 91. Heritage Pharmaceuticals Antiprotozoal Drugs Product Offerings
Table 92. Heritage Pharmaceuticals Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Heritage Pharmaceuticals Key News & Latest Developments
Table 94. Gilead Sciences Company Summary
Table 95. Gilead Sciences Antiprotozoal Drugs Product Offerings
Table 96. Gilead Sciences Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Gilead Sciences Key News & Latest Developments
Table 98. Johnson & Johnson Company Summary
Table 99. Johnson & Johnson Antiprotozoal Drugs Product Offerings
Table 100. Johnson & Johnson Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. Johnson & Johnson Key News & Latest Developments
Table 102. Bristol-Myers Squibb Company Summary
Table 103. Bristol-Myers Squibb Antiprotozoal Drugs Product Offerings
Table 104. Bristol-Myers Squibb Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 105. Bristol-Myers Squibb Key News & Latest Developments
Table 106. Profounda Company Summary
Table 107. Profounda Antiprotozoal Drugs Product Offerings
Table 108. Profounda Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 109. Profounda Key News & Latest Developments
Table 110. Knight Therapeutics Company Summary
Table 111. Knight Therapeutics Antiprotozoal Drugs Product Offerings
Table 112. Knight Therapeutics Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 113. Knight Therapeutics Key News & Latest Developments
Table 114. Albert David Company Summary
Table 115. Albert David Antiprotozoal Drugs Product Offerings
Table 116. Albert David Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 117. Albert David Key News & Latest Developments
Table 118. Wanlong Company Summary
Table 119. Wanlong Antiprotozoal Drugs Product Offerings
Table 120. Wanlong Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 121. Wanlong Key News & Latest Developments
Table 122. Fangsheng Company Summary
Table 123. Fangsheng Antiprotozoal Drugs Product Offerings
Table 124. Fangsheng Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 125. Fangsheng Key News & Latest Developments
Table 126. KPC Pharmaceuticals Company Summary
Table 127. KPC Pharmaceuticals Antiprotozoal Drugs Product Offerings
Table 128. KPC Pharmaceuticals Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 129. KPC Pharmaceuticals Key News & Latest Developments
Table 130. Guilin Pharmaceuticals Company Summary
Table 131. Guilin Pharmaceuticals Antiprotozoal Drugs Product Offerings
Table 132. Guilin Pharmaceuticals Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 133. Guilin Pharmaceuticals Key News & Latest Developments
Table 134. Pude Pharmaceutica Company Summary
Table 135. Pude Pharmaceutica Antiprotozoal Drugs Product Offerings
Table 136. Pude Pharmaceutica Antiprotozoal Drugs Revenue (US$, Mn) & (2018-2023)
Table 137. Pude Pharmaceutica Key News & Latest Developments
List of Figures
Figure 1. Antiprotozoal Drugs Segment by Type in 2022
Figure 2. Antiprotozoal Drugs Segment by Application in 2022
Figure 3. Global Antiprotozoal Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antiprotozoal Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Antiprotozoal Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antiprotozoal Drugs Revenue in 2022
Figure 8. By Type - Global Antiprotozoal Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Antiprotozoal Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Antiprotozoal Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Antiprotozoal Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Antiprotozoal Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Antiprotozoal Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Antiprotozoal Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Antiprotozoal Drugs Revenue Market Share, 2018-2030
Figure 16. US Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Antiprotozoal Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Antiprotozoal Drugs Revenue Market Share, 2018-2030
Figure 28. China Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Antiprotozoal Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Antiprotozoal Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Antiprotozoal Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Sanofi Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GlaxoSmithKline Plc Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Immuron Ltd Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Microbiotix Inc Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Protein Potential LLC Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Dr. Reddy?s Laboratories Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Mission Pharmacal Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Aceto Corp. Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Mylan Pharmaceuticals Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Impax Laboratories Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Pfizer Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Lupin Pharmaceuticals Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Glenmark Pharmaceuticals Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Sun Pharmaceutical Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Heritage Pharmaceuticals Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Gilead Sciences Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Johnson & Johnson Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Bristol-Myers Squibb Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Profounda Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Knight Therapeutics Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Albert David Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Wanlong Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Fangsheng Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. KPC Pharmaceuticals Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 66. Guilin Pharmaceuticals Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 67. Pude Pharmaceutica Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
